SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Tuesday reported a loss of $59.7 million in its first quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 28 cents.
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for a loss of 28 cents per share.
In the final minutes of trading on Tuesday, the company’s shares hit $1.11. A year ago, they were trading at $2.90.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
